1. Home
  2. LASE vs CNTX Comparison

LASE vs CNTX Comparison

Compare LASE & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Laser Photonics Corporation

LASE

Laser Photonics Corporation

N/A

Current Price

$0.83

Market Cap

55.3M

Sector

Industrials

ML Signal

N/A

Logo Context Therapeutics Inc.

CNTX

Context Therapeutics Inc.

N/A

Current Price

$0.31

Market Cap

47.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LASE
CNTX
Founded
2019
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
55.3M
47.7M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
LASE
CNTX
Price
$0.83
$0.31
Analyst Decision
Buy
Analyst Count
0
10
Target Price
N/A
★ $4.03
AVG Volume (30 Days)
★ 5.1M
1.0M
Earning Date
08-14-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 17.39
EPS
★ N/A
N/A
Revenue
★ $721,185.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.38
$0.31
52 Week High
$5.00
$3.62

Technical Indicators

Market Signals
Indicator
LASE
CNTX
Relative Strength Index (RSI) 38.49 32.52
Support Level $0.83 N/A
Resistance Level $0.93 $0.40
Average True Range (ATR) 0.07 0.03
MACD 0.01 0.00
Stochastic Oscillator 79.21 19.71

Price Performance

Historical Comparison
LASE
CNTX

About LASE Laser Photonics Corporation

Laser Photonics Corp is an integrated manufacturing company for photonics-based industrial products and solutions, laser cleaning technologies. Its laser-blasting technologies are focused on disrupting the sandblasting and abrasive blasting markets. The company offers a portfolio of integrated laser-blasting solutions for corrosion control, rust removal, de-coating, pre-welding and post-welding, laser cleaning, and surface conditioning. Its laser-blasting solutions are applicable in every industry dealing with materials processing, including automotive, aerospace, healthcare, consumer products, shipbuilding, machine manufacturing, nuclear maintenance and decommissioning, and surface coating. Geographically, the company generates almost all of its revenue from the domestic market.

About CNTX Context Therapeutics Inc.

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

Share on Social Networks: